The development of chiral ligands to fine-tune the stereocontrol has been recognized as a crucial pillar of asymmetric catalysis. In contrast to the well-developed chiral pyridine−pyridine-type and pyridine−oxazoline-type ligands, chiral oxazole− pyridine-type ligands have rarely been exploited. In this study, a class of [2.2]paracyclophane-based planar-chiral oxazole−pyridine N,N-ligands have been designed and synthesized. These ligands presented a superior performance in the enantioselective palladiumcatalyzed asymmetric acetoxylative cyclization of alkyne-tethered cyclohexadienones, providing the chiral cis-hydrobenzofurans that belong to bioactive molecules with potent NF-κB inhibition in broad substrate scope. These results demonstrated the promising potential of the chiral oxazole−pyridine ligands as an efficient type of N,N-ligand scaffold.